Financial Disclosures March 31, 2009 Daniel B. Mark, MD, MPH Professor of Medicine Director, Outcomes Research Duke University Medical Center Duke Clinical.
Cardiovascular Medications February 2002. Introduction Pharmacology versus Therapeutics Diseases –HTN –CAD –AMI –CHF –Arrhythmias –Thromboembolic.
Treatment and access to treatment in low and middle income countries Adeeba Kamarulzaman University of Malaya Kuala Lumpur, Malaysia ANRS-NIDA Joint Satellite.
Shock in the Pediatric Patient: or Oxygen Don’t Go Where the Blood Won’t Flow! James D. Fortenberry MD FAAP, FCCM Medical Director, PICU Division of Critical.
OVERVIEW OF TREATMENT OF CONGESTIVE HEART FAILURE.
Truncus Arteriosus CICU lecture January 7, 2011 Chrissy Sarlone.
Sergio Zanotti MD Assistant Professor of Medicine Robert Wood Johnson Medical School Cooper University Hospital Camden, New Jersey How useful and sensitive.
5/14/2015 1 Interim Results from HCV SPRINT-1 Phase 2 Study of Boceprevir Plus Peginterferon alfa-2b/Ribavirin in Treatment-Naïve Subjects with Genotype-1.
1© 2012 Lenovo Confidential. All rights reserved.1© 2011 Lenovo Confidential. All rights reserved. CHANNEL PROGRAMS 2013 PRODUCTSDO MORE WITH LENOVO.
Pulse analysis: stroke volume, vascular stiffening and cardiovascular disease Tom Archer, MD, MBA UCSD Anesthesia.
Mental Health, Substance Use, and HIV/HCV coinfection treatment Jeffrey J. Weiss, PhD Assistant Professor, Psychiatry Mount Sinai School of Medicine New.
Anna Duran, MD Janelle Aragon, MD. Objectives Have better understanding of Pediatric BLS Understand presentation of shock and treatment Be able.